Follow Us

Global Flow Cytometry Market Size, Segmentation, Trends and Growth Analysis Forecast by 2031

  •   DLR5171
  •   June, 2024
  •   Pages: 130
  •  Global

Flow Cytometry Market Overview and Analysis:

The Global Flow Cytometry Market size is estimated at USD 7.2 billion in 2023 and is expected to reach a CAGR of 9.02% during the forecast period (2024-2031).

Flow Cytometry Market

Get Complete Analysis Of The Report - Download Free Sample PDF

Flow cytometry is a powerful technique in biology and medicine used to analyze and quantify the characteristics of particles, typically cells, as they flow through a laser beam in a fluid. Cells are labelled with fluorochrome dyes, and as they pass through the laser, detectors measure light scattering and emitted fluorescence. This provides information about cell size, granularity, and internal complexity, allowing for the identification and quantification of specific cell populations based on surface or intracellular markers. Flow cytometry is widely employed in immunology, haematology, microbiology, and oncology, enabling researchers and clinicians to study cell populations, identify subpopulations, analyze cell cycle phases, and assess cellular functions such as apoptosis and proliferation. It is a versatile tool for various applications, including immunophenotyping, cell sorting, and detailed cellular analysis.

The global flow cytometry market has been driven by several key factors that contribute to its growth and adoption across various sectors. One primary driver is the increasing prevalence of diseases, particularly cancer and immunological disorders, leading to a growing demand for advanced diagnostic and research tools. Flow cytometry's ability to provide detailed and rapid analysis of cells at the single-cell level has made it invaluable in clinical diagnostics and medical research. Moreover, the expanding applications of flow cytometry in drug discovery and development processes, as well as the rising focus on personalized medicine, have further propelled market growth. Continuous technological advancements, including the development of high-throughput systems, more sophisticated fluorochrome labels, and advanced data analysis software, have enhanced the capabilities and efficiency of flow cytometers, making them essential tools in laboratories worldwide. The global emphasis on life sciences research and the increasing investments in healthcare infrastructure have also played pivotal roles in driving the expansion of the flow cytometry market. Overall, the combination of technological innovation, broadening applications, and the pressing need for accurate and efficient cell analysis has positioned flow cytometry as a key player in the global life sciences and diagnostic markets.

Market Segmentation: The Global Flow Cytometry Market is Segmented by Product Type (Instrument, Kit and Reagent, Software, and Services), Technology (Cell-based Flow Cytometry and Bead-based Flow Cytometry), Application (Oncology, Drug Discovery, Stem Cell Therapy Organ Transplantation, Hematology, and Other Applications), End User (Hospitals and Clinics, Academia and Research Institutes, Pharmaceutical and Biotechnology Companies, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Flow Cytometry Market Segment

For Detailed Market Segmentation - Download Free Sample PDF

Flow Cytometry Market Trends:

The market was witnessing growth driven by factors such as increasing applications in clinical diagnostics, cancer research, and immunology. Technological advancements, including the development of high-throughput flow cytometry systems and advanced analysis software, were enhancing the capabilities and efficiency of flow cytometers. Additionally, the rising prevalence of chronic diseases, along with the growing emphasis on personalized medicine, was contributing to the demand for flow cytometry in healthcare settings. The Asia-Pacific region was emerging as a significant market due to increasing research activities and healthcare infrastructure development. Furthermore, collaborations and partnerships among key market players were observed, fostering innovation and expanding the product portfolios in the global flow cytometry market. It's important to note that the current market trends may have evolved since then, and for the latest information, one should refer to the most recent reports and industry analyses.

Market Drivers:

Growing Adoption of Flow Cytometry in Stem Cell Research

The growing adoption of flow cytometry in stem cell research has become a significant trend, marking a pivotal advancement in the study and understanding of stem cells. Flow cytometry, with its ability to analyze individual cells with precision, has proven to be an indispensable tool for researchers in characterizing and isolating different types of stem cells based on their surface markers. This technology enables scientists to profile heterogeneous stem cell populations, identifying and sorting cells with specific markers that indicate their differentiation status or functional properties. In stem cell research, flow cytometry is extensively used for the identification and isolation of rare stem cell subpopulations, such as hematopoietic stem cells and mesenchymal stem cells, among others. Researchers leverage flow cytometry to assess the expression of specific cell surface markers, allowing for the isolation of pure and viable stem cell populations for further analysis and experimentation.

Additionally, flow cytometry plays a crucial role in monitoring and studying the differentiation of stem cells into various lineages, providing insights into the dynamic processes of cellular development. The technology's ability to analyze multiple parameters simultaneously, such as cell size, granularity, and the expression of multiple markers, enhances the depth and accuracy of stem cell characterization. As stem cell research continues to evolve, the adoption of flow cytometry has become integral to advancing our understanding of stem cell biology, paving the way for potential therapeutic applications in regenerative medicine, tissue engineering, and personalized medicine. The synergy between flow cytometry and stem cell research holds promise for unlocking the full potential of stem cells in addressing various medical challenges and advancing the field towards innovative and targeted therapies. Thus, such factors are expected to drive the growth of the studied market over the forecast period.

Increasing Applications of Flow Cytometry in Clinical Research

Flow cytometry has become increasingly integral to clinical research, offering diverse applications that enhance diagnostic and investigative capabilities. In immunophenotyping, it aids in characterizing immune cell populations, facilitating the diagnosis and monitoring of immunological disorders. In hematology, flow cytometry provides precise analysis of blood cell types, aiding in the detection and monitoring of hematological malignancies. Its applications extend to infectious diseases, where it enables the study of immune responses, progression of infections, and vaccine efficacy. In oncology, flow cytometry plays a crucial role in identifying and characterizing cancer cells, contributing to prognosis, treatment stratification, and targeted therapy development. The technology's multiparametric analysis capabilities make it invaluable across various clinical domains, including pharmacology, transplantation, and autoimmune disorders, positioning flow cytometry as a versatile and indispensable tool in advancing our understanding of diseases and improving clinical diagnostics and treatment strategies.

Market Restraints:

Lack of Awareness about the Potential Benefits of Flow Cytometry Techniques

The growth of the flow cytometry market may be hindered by a lack of awareness about the potential benefits of flow cytometry techniques. Despite the widespread applications and advancements in this technology, there exists a notable gap in awareness among potential users, including researchers, clinicians, and healthcare professionals. The intricate capabilities of flow cytometry in analyzing individual cells, profiling cell populations, and providing valuable insights into cellular functions are often underappreciated or misunderstood by those who could benefit from its use. The lack of awareness may result in the underutilization of flow cytometry in various fields such as immunology, oncology, and stem cell research, potentially slowing down market growth. Bridging this awareness gap through educational initiatives, training programs, and increased dissemination of success stories and case studies could play a pivotal role in unlocking the full potential of flow cytometry and fostering its wider adoption across diverse scientific and medical disciplines.

COVID-19 Impact on Flow Cytometry Market:

The trajectory of the flow cytometry market has been noticeably influenced by the COVID-19 pandemic. Notably, the pandemic spurred increased utilization of flow cytometry in response to the global health crisis. A noteworthy example is highlighted in a January 2022 article published in the journal Frontiers in Immunology, which introduced a high-throughput screening system based on flow cytometry for testing COVID-19 cases. This system utilized a mechanism where virus particles bound to specific primary antibodies, forming virus-antibody complexes that subsequently bound to fluorescently tagged secondary antibodies. The resulting fluorescence signal could then be measured in a flow channel, allowing for the qualitative detection of the virus in test samples. During the peak of the pandemic, flow cytometry emerged as a valuable tool in the diagnosis of COVID-19 samples, showcasing its versatility in responding to emergent healthcare challenges. However, with the gradual decrease in COVID-19 cases in the current scenario, the demand for flow cytometry is expected to stabilize compared to the heightened levels observed at the pandemic's onset. Nevertheless, research within the pharmaceutical and healthcare industries indicates a sustained and significant growth trajectory for the demand for flow cytometry over the forecast period. This suggests that while the immediate surge in demand due to the pandemic may subside, the overall trajectory of growth for flow cytometry remains robust, driven by ongoing developments and applications across various sectors.

Segmental analysis:

Instrument Segment is Expected to Witness Significant Growth over the Forecast Period

Instrumentation is pivotal in the field of flow cytometry, serving as the cornerstone for accurate and efficient cellular analysis. Flow cytometers consist of essential components, including a flow cell, laser light sources, detectors, and electronic systems. The flow cell ensures a controlled single-file passage of cells through the instrument, while lasers illuminate the cells as they pass through, causing them to scatter light in distinct patterns. Detectors capture this scattered light at various angles, and fluorochrome dyes, used for cell labelling, emit fluorescence that is also detected. Electronic systems process this data, providing detailed information on cell size, granularity, and fluorescence characteristics. Advanced flow cytometers with multiple detectors enable simultaneous analysis of multiple parameters, enhancing their versatility. The continuous evolution of instrumentation in flow cytometry contributes to the precision and speed of cellular analysis, making it an indispensable tool in scientific and medical research, with ongoing advancements ensuring its relevance and effectiveness across diverse applications.

Cell-based Flow Cytometry Segment is Expected to Witness Significant Growth over the Forecast Period

Cell-based flow cytometry is a specialized application of flow cytometry that focuses on the analysis and characterization of individual cells within a heterogeneous population. This technique allows researchers to investigate various cellular properties, such as size, shape, granularity, and fluorescence, providing valuable insights into the composition and behavior of different cell types. In cell-based flow cytometry, cells are typically labeled with fluorescent dyes or antibodies targeting specific cell surface markers, allowing for the identification and sorting of distinct cell populations. This method is widely employed in immunology, hematology, oncology, and other fields to study immune cell subsets, identify disease markers, and assess cellular functions. Cell cycle analysis, apoptosis detection, and the study of signaling pathways are among the diverse applications of cell-based flow cytometry. The technology's ability to provide quantitative and qualitative information about individual cells in a high-throughput manner makes it an essential tool for advancing our understanding of cellular biology and its implications in health and disease. The continuous development of more sophisticated reagents and instrumentation further enhances the capabilities of cell-based flow cytometry, making it an invaluable resource for researchers and clinicians in various scientific disciplines.

Stem Cell Therapy Segment is Expected to Witness Significant Growth over the Forecast Period

Stem cell therapy and flow cytometry form a synergistic partnership in advancing regenerative medicine and personalized treatments. Flow cytometry plays a crucial role in the characterization, isolation, and quality control of stem cells, ensuring their suitability for therapeutic applications. In stem cell therapy, flow cytometry enables the identification and purification of specific stem cell populations based on surface markers, allowing researchers to isolate cells with desired characteristics, such as pluripotency or differentiation potential. This technology facilitates the monitoring of stem cell differentiation, ensuring the development of the intended cell lineages for therapeutic purposes. Additionally, flow cytometry is instrumental in assessing the viability, homogeneity, and purity of stem cell preparations, critical parameters for successful transplantation and engraftment. The ability to analyze multiple parameters simultaneously, such as cell surface markers and intracellular factors, enhances the precision of stem cell characterization. As stem cell therapy continues to evolve, the integration of flow cytometry remains essential for optimizing the therapeutic potential of stem cells, contributing to the development of innovative treatments for a variety of diseases and injuries. The combination of these technologies holds promise for pushing the boundaries of regenerative medicine, offering tailored and effective solutions for patients in need of advanced therapeutic interventions.

Academia and Research Institutes Segment is Expected to Witness Significant Growth over the Forecast Period

Academia and research institutes play a crucial role in advancing the field of flow cytometry, serving as hubs for innovative research and discoveries across diverse scientific domains. Flow cytometry has become an indispensable tool in academic settings, offering precise insights into cellular characteristics and facilitating in-depth studies in immunology, cancer research, microbiology, and stem cell biology. These institutions often house cutting-edge flow cytometry facilities, fostering interdisciplinary collaborations and enabling researchers to explore the complexities of cell biology. Flow cytometry's versatility allows for quantitative and multiparametric analysis, contributing not only to basic research but also extending its applications to preclinical studies, drug development, and clinical trials. Beyond utilizing existing technologies, academia actively contributes to the evolution of flow cytometry by developing novel techniques, reagents, and instrumentation. Training programs and collaborative efforts with flow cytometry manufacturers ensure that researchers are equipped with the skills and resources needed to harness the full potential of flow cytometry, thereby driving continuous innovation and shaping the landscape of scientific inquiry and medical advancements. Thus, such factors are expected to drive the growth of the segment.

North America Region is Expected to Witness Significant Growth over the Forecast Period

The North American region, comprising the United States, Canada, and Mexico, is poised for substantial growth in the forecast period, driven by various factors. Mexico is experiencing an increase in leishmaniasis cases, and the significance of flow cytometry in determining patient prognosis has grown with advancements in disease detection and drug resistance measurement. A December 2022 article in the Tropical Medicine and Infectious Disease journal highlighted the rising leishmania cases in Mexico over the past five years, indicating a potential surge in demand for flow cytometry for prognosis determination. Additionally, the prevalence of HIV cases in Canada, with an estimated 62,790 people living with HIV during 2020-2021, is expected to drive demand for frequent disease diagnosis and, consequently, an increased need for flow cytometry. The region's market growth is further supported by ongoing research and development projects, exemplified by the University of North Dakota's Center of Biomedical Research Excellence (CoBRE) in host-pathogen interactions. The NIH-funded project focuses on understanding the body's response to infections, supporting innovative research with core facilities, including flow cytometry. Furthermore, the market is boosted by new product releases, such as Thermo Fisher Scientific's Invitrogen Attune CytPix Flow Cytometer launched in June 2021. This imaging-enhanced flow cytometer employs a high-speed camera and acoustic focusing flow cytometry technology, enabling users to collect high-performance fluorescent flow cytometry data while obtaining high-resolution brightfield images. The combination of rising disease cases, ongoing research endeavors, and innovative product launches positions the North American flow cytometry market for significant growth in the upcoming years.

Flow Cytometry Market table

Get Complete Analysis Of The Report - Download Free Sample PDF

Flow Cytometry Market Competitive Landscape:

The Flow Cytometry Market is characterized by its competitive nature, marked by the presence of numerous key players. These market participants currently command significant market shares and are anticipated to continue operating within a competitive landscape in the foreseeable future. The industry's competitiveness is underscored by the strong market positions held by these players. It is expected that these established entities will maintain their prominence, fostering an environment where competition remains intense. The dynamic and competitive nature of the market suggests that these key players will continue to influence market dynamics and shape industry trends over the coming years. The presence of multiple players vying for market share underscores the industry's robustness, as companies strive to innovate and differentiate themselves in this competitive arena. Some of the key market players working in this market segment are:

  • Becton, Dickinson and Company
  • Danaher corporation (Beckman Coulter Inc.)
  • Stratedigm Inc.
  • Bio-Rad Laboratories Inc.
  • Luminex Corporation
  • Miltenyi Biotech
  • Sysmex Corporation
  • Agilent Technologies Inc.
  • ThermoFisher Scientific Inc.
  • Sony Biotechnology Inc. (Sony Corporation of America)
  • BioMerieux SA
  • Enzo Biochem Inc. (Enzo Life Sciences Inc.)

Recent Development:

1) In November 2022, Sony Corporation introduced the SFA-Life Sciences Cloud Platform, a cloud-based solution designed for the analysis of flow cytometry data. This innovative platform facilitates the identification of rare cells, including cancer cells and stem cells, within extensive cell populations. Leveraging data generated by flow cytometers, the solution simplifies the process of pinpointing specific cells in large datasets.

2) In September 2022, Becton, Dickinson, and Company launched BD Research Cloud, a cloud-based software solution aimed at streamlining the workflow of flow cytometry. This software is tailored to assist scientists across diverse fields, such as immunology, virology, oncology, and infectious disease monitoring, enabling them to conduct more efficient experiments and obtain quicker results.

Frequently Asked Questions (FAQ) :

Q1. What was the Flow Cytometry Market size in 2023?

As per Data Library Research the Global Flow Cytometry Market size is estimated at USD 7.2 billion in 2023.

Q2. What is the Growth Rate of the Flow Cytometry Market?

Flow Cytometry Market is expected to reach a CAGR of 9.02% during the forecast period.

Q3. What are the factors driving the Flow Cytometry Market?

Key factors that are driving the growth include theGrowing Adoption of Flow Cytometry in Stem Cell Research and Increasing Applications of Flow Cytometry in Clinical Research.

Q4. Who are the key players in Flow Cytometry market?

Some key players operating in the market include

  • Becton, Dickinson and Company
  • Danaher corporation (Beckman Coulter Inc.)
  • Stratedigm Inc.
  • Bio-Rad Laboratories Inc.

Request for TOC

Request for List of Figure

Research Process

Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.

In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization



Primary Research

Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.

In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.

It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.

Secondary Research

Secondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.

Market Size Estimation

Both, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.

Forecast Model